- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Devin Incerti: Use Value Assessments to Maximize the Well-Being of a Population
If you set social benefits equal to social costs, you will be able to maximize the well-being of a population, and that's what value assessment allows for, explained Devin Incerti, PhD, lead economist, Innovation and Value Initiative.
If you set social benefits equal to social costs, you will be able to maximize the well-being of a population, and that's what value assessment allows for, explained Devin Incerti, PhD, lead economist, Innovation and Value Initiative.
Transcript
What are some alternatives to health technology assessments that has the greatest promise?
I think maybe one of the first questions that I always ask myself is: what is really the purpose of value assessment and what is the purpose of allocating resources in healthcare? In my mind, we’re really trying to maximize the well-being of the population. And to do that, it turns out, we know that from economic theory that you can do that if you set the social benefits equal to the social costs, and value assessment provides a very nice way to do that. In most markets, such as the markets for private goods, buyers and sellers pay for things and we know their willingness to pay, but we don’t actually have that in healthcare and because of that, we kind of need to have something that almost attempting to do that but isn't quite right, and value assessment is exactly that. So, maybe it doesn’t quite answer the question, but in my mind value assessments actually get at the best of our ability and that’s exactly what we’re trying to get at, which is to maximize the well-being of the population.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
